Applied StemCell

TGA BioServices, an Absorption Systems'​ Company, is an FDA inspected contract research laboratory providing the Pharmaceutical, Biotechnology and Research communities a comprehensive range of laboratory services in support of research and clinical studies. We offer the client a complete package of customized testing systems utilized in preclinical through Phase IV studies, all in compliance with cGLP and cGMP requirements.

We specialize in the development and validation of immunoassay systems for the detection of target molecules, antibody responses and quantification in total compliance with QA and cGMP standards.

TGA BioServices also offers in vivo mouse studies for the optimization of vaccine immunization schedules, dosing, adjuvant screening, immunogenicity testing for the release and stability of bulk and finished clinical product, as well as complete antibody development programs. Furthermore, we offer Guinea pig dermal sensitization testing for the identification of contact allergens. All programs are supervised by an in-house Institutional Animal Care and Use Committee (IACUC), while the facility is USDA registered and AAALAC accredited.

Other services provided include FACScan cell labeling studies, tissue culture, endotoxin testing, basic R&D activities, sample storage, specimen collection kits with on-site training, data management, protocol generation (SOP), database/statistical analysis and consultation. TGA BioServices has the credentials your project is searching for.

At Qoolabs, we use the QMab™ (Quick Monoclonal Antibody from Blood) platform to generate novel antibodies. Rabbit monoclonal antibodies are cloned from blood in three weeks when immunized rabbits are ready, with no need of killing animals. Antibodies can be cloned from blood collected at multiple time points and selected with functional assays. To learn more about the QMab™ technology, please email your inquiry to info@qoolabs.com.

We are highly skilled in developing lateral flow rapid tests and ELISAs. Our featured products are His-tag and Fc-fusion protein rapid tests, biotin quantitation kits, CMV antibody rapid tests, and Hepatitis B virus core antigen ELISA kits. 37ExpressVue® Rapid Tests detect recombinant fusion protein or epitope tagged proteins of interest. KnowNow!® Rapid Tests detect native proteins directly from biological samples and culture media. QNow® Quantitative Rapid Tests quantitate target molecules. QTiter™ ELISA kits are highly sensitive and specific. Visit our website www.qoolabs.com for product info, or contact us at “info@qoolabs.com” for custom immunoassay development.

Altogen Labs is a biology CRO company providing GLP preclinical research services, tox studies for IND applications, RNAi and gene silencing services, xenograft testing services (100+ tumorigenic cell lines), in vivo siRNA delivery and biodistribution, development of stable cell lines, and many more.

Altogen Labs is a GLP compliant laboratory that provides preclinical research and biotechnology contract research services (CRO) to pharma, biotechnology companies, universities, and cancer research centers worldwide. Our services include pharmacology and toxicology assays (IC50), cell banking, generation of stable cell lines, RNAi gene silencing and other in vitro services. Altogen Labs provides following in vivo services for efficacy studies in the drug discovery phase: rodent xenograft models, teratoma formation and analysis services, cancer disease animal models, in vivo siRNA delivery and tissue targeting, pharmacokinetics (PK) and pharmacodynamics (PD) services, immune response and biomarker analysis.

Altogen Labs recently developed an `active bioremediation`​ process based on an approach using the most potent oil-degrading bacteria found at multiple oil spill sites in Texas. This technology allows remediation of large amounts of hydrocarbon-contaminated liquids or soil. The genomes of both microorganisms were recently sequenced, which revealed that both strains were previously unreported in the literature. Altogen Labs filed bioremeddiation patent application in 6/2012.

Biotechnology Company Offering Custom Antibody and Protein Services.
- Monoclonal antibody development
- Polyclonal antibody development
- Gene cloning and expression
- In vitro antibody production & purifications
- Cell line engineering, rescue, & banking
- Assay development, ELISA and diagnostics
- Immuno assays and services
- Nanogold, nanosilver and nanoplatinum products

We are a Life Science company developing innovative enzyme assay formats for a quantum improvement in performance and productivity. Our PhosphoSens® next generation Sox-based sensor platform uses proprietary technology invented in the Imperiali laboratory at MIT and is exclusively licensed to AssayQuant®. This format provides a simple and powerful solution to quantitatively measure the activity of protein kinases and phosphatases, with specificity for Tyr, Ser/Thr, or Mixed Function, using a direct, one-step homogeneous and continuous (kinetic) format. Samples can be recombinant or immunoprecipitated enzymes or crude cell or tissue lysates and assays can be read on commonly available microplate readers. This platform is ideal for elucidating drug mechanism of action, profiling and potency assessments. With multiple formats including PhosphoSens®, PhosphoSens®-Lysate and PhosphoSens®-Red and the ability to target different enzyme classes, our technologies are being applied across the discovery and drug development workflow to characterize next generation enzyme inhibitors and activators.

Contact us on our website or hello@assayquant.com to learn how our Catalog products and Custom Assay Development or Testing Services can enable your efforts.